Fasciolosis, caused by Fasciola hepatica and F. gigantica, is an important veterinary disease of livestock, leading to health complications and substantial economic losses. The eggs produced by the adult flukes pass out of the host along with the feces that ensure the propagation of their infection and lifecycle. Therefore, targeting the eggs to control this parasite could check the snail infection and the completion of life cycle, and the spread of fasciolosis. The present study evaluated the ovicidal activities of ethanolic extract of Azadirachta indica leaf and its green-synthesized silver nanoparticles (AI-AgNPs) against F. gigantica eggs in comparison with triclabendazole (TCBZ) in vitro. A. indica extract and AI-AgNPs were prepared and characterized following standard protocols. The eggs were incubated in distilled water (DW) containing 1, 2 and 4 mg/ml A. indica leaf extract, AI-AgNPs, and 1.5 µg/ml TCBZ at 28 ± 1 °C for 24 h and then in DW for 14 days. The effects of treatment were assessed based on the inhibition of development and hatchability of eggs at various stages. The LC50 and LC90 for AI-AgNPs were significantly lower (0.53 mg/ml and 2.62 mg/ml, respectively) than neem extract (1.46 mg/ml and 16.7 mg/ml) and TCBZ (1.47 µg/ml and 3.54 µg/ml). AI-AgNPs showed an ovicidal activity of 95.18 % at 4 mg/ml, significantly higher than the neem extract (71.48 %) and TCBZ (75.49 %). Statistical analysis showed that AI-AgNPs had a significant impact on mortality across various developmental stages. The present study suggests that AI-AgNPs could offer an alternative to conventional anthelmintics like TCBZ.
扫码关注我们
求助内容:
应助结果提醒方式:
